Jacobs Levy Equity Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Sell |
846,533
-451,252
| -35% | -$244K | ﹤0.01% | 895 |
|
|
2025
Q1 | $851K | Buy |
1,297,785
+555,323
| +75% | +$364K | ﹤0.01% | 840 |
|
|
2024
Q4 | $757K | Sell |
742,462
-729,255
| -50% | -$744K | ﹤0.01% | 755 |
|
|
2024
Q3 | $1.27M | Sell |
1,471,717
-1,479,227
| -50% | -$1.28M | ﹤0.01% | 682 |
|
|
2024
Q2 | $1.06M | Buy |
2,950,944
+2,758,995
| +1,437% | +$989K | ﹤0.01% | 729 |
|
|
2024
Q1 | $129K | Sell |
191,949
-816,113
| -81% | -$547K | ﹤0.01% | 909 |
|
|
2023
Q4 | $548K | Buy |
1,008,062
+604,280
| +150% | +$328K | ﹤0.01% | 816 |
|
|
2023
Q3 | $242K | Buy |
403,782
+195,734
| +94% | +$117K | ﹤0.01% | 900 |
|
|
2023
Q2 | $270K | Sell |
208,048
-313,943
| -60% | -$408K | ﹤0.01% | 895 |
|
|
2023
Q1 | $919K | Buy |
521,991
+404,467
| +344% | +$712K | 0.01% | 716 |
|
|
2022
Q4 | $369K | Sell |
117,524
-12,265
| -9% | -$38.5K | ﹤0.01% | 836 |
|
|
2022
Q3 | $636K | Buy |
129,789
+30,779
| +31% | +$151K | 0.01% | 796 |
|
|
2022
Q2 | $410K | Buy |
+99,010
| New | +$410K | ﹤0.01% | 892 |
|
|
2018
Q1 | – | Sell |
-40,540
| Closed | -$665K | – | 1053 |
|
|
2017
Q4 | $665K | Buy |
40,540
+9,200
| +29% | +$151K | 0.01% | 699 |
|
|
2017
Q3 | $470K | Buy |
+31,340
| New | +$470K | 0.01% | 715 |
|